General and inducible hypermutation facilitate parallel adaptation in Pseudomonas aeruginosa despite divergent mutation spectra

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 34, 2012, Pages 13680-13685

  Weigand, Michael R ^a,b   Sundin, George W ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b Georgia Institute of Technology   (United States)

Author keywords

MutS; RulAB

Indexed keywords

BACTERIAL PROTEIN; RIFAMPICIN; RNA POLYMERASE BETA SUBUNIT;

ADAPTATION; AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BIOCHEMICAL COMPOSITION; DNA SEQUENCE; GENE FREQUENCY; GENE LOCUS; GENOME ANALYSIS; GENOTYPE; MOLECULAR EVOLUTION; MUTATIONAL ANALYSIS; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SEQUENCE ANALYSIS;

ACCLIMATIZATION; BACTERIAL PROTEINS; DNA MUTATIONAL ANALYSIS; DNA REPAIR; DNA-DIRECTED DNA POLYMERASE; GENOME; GENOME, BACTERIAL; MODELS, GENETIC; MOLECULAR SEQUENCE DATA; MUTATION; POINT MUTATION; PSEUDOMONAS AERUGINOSA; RIFAMPIN;

EID: 84865279338     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1205357109     Document Type: Article

References (37)

1. Sniegowski PD, Gerrish PJ, Johnson T, Shaver A (2000) The evolution of mutation rates: Separating causes from consequences. Bioessays 22:1057-1066.
2. de Visser JAGM (2002) The fate of microbial mutators. Microbiology 148:1247-1252.
3. Sundin GW, Weigand MR (2007) The microbiology of mutability. FEMS Microbiol Lett 277:11-20.
4. Hall LMC, Henderson-Begg SK (2006) Hypermutable bacteria isolated from humans - a critical analysis. Microbiology 152:2505-2514.
5. Oliver A, Mena A (2010) Bacterial hypermutation in cystic fibrosis, not only for antibiotic resistance. Clin Microbiol Infect 16:798-808.
6. Hogardt M, et al. (2007) Stage-specific adaptation of hypermutable Pseudomonas aeruginosa isolates during chronic pulmonary infection in patients with cystic fibrosis. J Infect Dis 195:70-80.
7. Mena A, et al. (2008) Genetic adaptation of Pseudomonas aeruginosa to the airways of cystic fibrosis patients is catalyzed by hypermutation. J Bacteriol 190:7910-7917.
8. Schlacher K, Goodman MF (2007) Lessons from 50 years of SOS DNA-damage-induced mutagenesis. Nat Rev Mol Cell Biol 8:587-594.
9. Kim JJ, Sundin GW (2000) Regulation of the rulAB mutagenic DNA repair operon of Pseudomonas syringae by UV-B (290 to 320 nanometers) radiation and analysis of rulAB-mediated mutability in vitro and in planta. J Bacteriol 182:6137-6144.
10. Erill I, Campoy S, Barbé J (2007) Aeons of distress: An evolutionary perspective on the bacterial SOS response. FEMS Microbiol Rev 31:637-656.
11. Andersson DI, Koskiniemi S, Hughes D (2010) Biological roles of translesion synthesis DNA polymerases in eubacteria. Mol Microbiol 77:540-548.
12. Elena SF, Lenski RE (2003) Evolution experiments with microorganisms: The dynamics and genetic bases of adaptation. Nat Rev Genet 4:457-469.
13. Herring CD, et al. (2006) Comparative genome sequencing of Escherichia coli allows observation of bacterial evolution on a laboratory timescale. Nat Genet 38:1406-1412.
14. Hegreness M, Kishony R (2007) Analysis of genetic systems using experimental evolution and whole-genome sequencing. Genome Biol 8:201.
15. Weigand MR, Sundin GW (2009) Long-term effects of inducible mutagenic DNA repair on relative fitness and phenotypic diversification in Pseudomonas cichorii 302959. Genetics 181:199-208.
16. Cramer N, et al. (2011) Microevolution of the major common Pseudomonas aeruginosa clones C and PA14 in cystic fibrosis lungs. Environ Microbiol 13:1690-1704.
17. Garibyan L, et al. (2003) Use of the rpoB gene to determine the specificity of base substitution mutations on the Escherichia coli chromosome. DNA Repair (Amst) 2:593-608.
18. Campbell EA, et al. (2001) Structural mechanism for rifampicin inhibition of bacterial rna polymerase. Cell 104:901-912.
19. Jatsenko T, Tover A, Tegova R, Kivisaar M (2010) Molecular characterization of Rif(r) mutations in Pseudomonas aeruginosa and Pseudomonas putida. Mutat Res 683:106-114.
20. Stover CK, et al. (2000) Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen. Nature 406:959-964.
21. Klockgether J, et al. (2010) Genome diversity of Pseudomonas aeruginosa PAO1 laboratory strains. J Bacteriol 192:1113-1121.
22. Grant JR, Stothard P (2008) The CGView Server: A comparative genomics tool for circular genomes. Nucleic Acids Res 36(Web Server issue):W181-4.
23. Barrick JE, et al. (2009) Genome evolution and adaptation in a long-term experiment with Escherichia coli. Nature 461:1243-1247.
24. Barrick JE, Kauth MR, Strelioff CC, Lenski RE (2010) Escherichia coli rpoB mutants have increased evolvability in proportion to their fitness defects. Mol Biol Evol 27:1338-1347.
25. Hall AR, Iles JC, MacLean RC (2011) The fitness cost of rifampicin resistance in Pseudomonas aeruginosa depends on demand for RNA polymerase. Genetics 187:817-822.
26. Oliver A, Cantón R, Campo P, Baquero F, Blázquez J (2000) High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. Science 288:1251-1254.
27. Schaaper RM, Dunn RL (1987) Spectra of spontaneous mutations in Escherichia coli strains defective in mismatch correction: The nature of in vivo DNA replication errors. Proc Natl Acad Sci USA 84:6220-6224.
28. Smania AM, et al. (2004) Emergence of phenotypic variants upon mismatch repair disruption in Pseudomonas aeruginosa. Microbiology 150:1327-1338.
29. Chandler MG, Pritchard RH (1975) The effect of gene concentration and relative gene dosage on gene output in Escherichia coli. Mol Gen Genet 138:127-141.
30. Fijalkowska IJ, Dunn RL, Schaaper RM (1997) Genetic requirements and mutational specificity of the Escherichia coli SOS mutator activity. J Bacteriol 179:7435-7445.
31. Simonson CS, Kokjohn TA, Miller RV (1990) Inducible UV repair potential of Pseudomonas aeruginosa PAO. J Gen Microbiol 136:1241-1249.
32. Jacobs JL, Carroll TL, Sundin GW(2005) The role of pigmentation, ultraviolet radiation tolerance, and leaf colonization strategies in the epiphytic survival of phyllosphere bacteria. Microb Ecol 49:104-113.
33. Moyano AJ, Luján AM, Argaraña CE, Smania AM (2007) MutS deficiency and activity of the error-prone DNA polymerase IV are crucial for determining mucA as the main target for mucoid conversion in Pseudomonas aeruginosa. Mol Microbiol 64:547-559.
34. Gibson RL, Burns JL, Ramsey BW (2003) Pathophysiology and management of pulmonary infections in cystic fibrosis. Am J Respir Crit Care Med 168:918-951.
35. Schelstraete P, et al. (2008) Pseudomonas aeruginosa in the home environment of newly infected cystic fibrosis patients. Eur Respir J 31:822-829.
36. Stokes HW, Krishnapillai V (1978) Prevalence of Pseudomonas aeruginosa FP plasmids which enhance spontaneous and uv-induced mutagenesis. Mutat Res 50:19-28.
37. Ohmori H, et al. (2001) The Y-family of DNA polymerases. Mol Cell 8:7-8.